Although MSUT2 is a promising modulator of tau pathology in transgenic animal models with tau overexpression, little is known about the effectiveness of MSUT2 suppression in inhibiting sporadic forms of tauopathies without tau overexpression. The gene discussed is MAPT; the disease is tauopathy.